Small Molecules as Toll-like Receptor 4 Modulators Drug and

docking drug repurposing innate immunity toll-like receptor 4 virtual screening

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
19 Sep 2022
Historique:
received: 22 07 2022
revised: 08 09 2022
accepted: 09 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

The innate immunity toll-like receptor 4 (TLR4) system is a receptor of paramount importance as a therapeutic target. Virtual screening following a "computer-aided drug repurposing" approach was applied to the discovery of novel TLR4 modulators with a non-lipopolysaccharide-like structure. We screened almost 29,000 approved drugs and drug-like molecules from commercial, public, and

Identifiants

pubmed: 36140427
pii: biomedicines10092326
doi: 10.3390/biomedicines10092326
pmc: PMC9496124
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Economy, Industry and Competitiveness
ID : CTQ2014-57141-R
Organisme : Ministry of Economy, Industry and Competitiveness
ID : CTQ2017-88353-R
Organisme : Ministry of Economy, Industry and Competitiveness
ID : BES-2012-053653
Organisme : Ministry of Economy, Industry and Competitiveness
ID : BES-2015-071588
Organisme : Ministry of Economy, Industry and Competitiveness
ID : SAF2016-75988-R
Organisme : Ministry of Economy, Industry and Competitiveness
ID : PID2020-113588RB-I00
Organisme : Comunidad de Madrid
ID : S-2010/BMD-2332

Références

Curr Top Med Chem. 2014;14(23):2672-83
pubmed: 25515751
Chem Biol Drug Des. 2016 Aug;88(2):217-29
pubmed: 26896420
Drug Des Devel Ther. 2013 Aug 08;7:753-66
pubmed: 23966771
Eur J Pharm Sci. 2013 Jan 23;48(1-2):21-9
pubmed: 23131797
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Chemistry. 2021 Nov 5;27(62):15406-15425
pubmed: 34569111
Nat Rev Drug Discov. 2004 Aug;3(8):673-83
pubmed: 15286734
Molecules. 2016 Jul 30;21(8):
pubmed: 27483231
Future Med Chem. 2018 Feb;10(4):461-476
pubmed: 29380635
Molecules. 2022 Feb 05;27(3):
pubmed: 35164339
Drug Discov Today. 2002 Oct 15;7(20):1047-55
pubmed: 12546894
Pharmacotherapy. 2010 Jul;30(7 Pt 2):51S-4S
pubmed: 20575622
J Chem Inf Model. 2007 Mar-Apr;47(2):279-94
pubmed: 17381166
Expert Rev Clin Immunol. 2014 Oct;10(10):1277-9
pubmed: 25161080
J Mark Access Health Policy. 2013 Aug 06;1:
pubmed: 27226826
Int Immunopharmacol. 2011 Jan;11(1):19-22
pubmed: 20939996
Nat Rev Rheumatol. 2016 Jun;12(6):344-57
pubmed: 27170508
J Immunol. 2010 Feb 15;184(4):2219-25
pubmed: 20083671
Drug Discov Today Technol. 2004 Dec;1(4):337-41
pubmed: 24981612
Nature. 2007 Aug 9;448(7154):645-6
pubmed: 17687303
J Med Chem. 2002 Jun 6;45(12):2615-23
pubmed: 12036371
Int J Cancer. 2022 Jan 1;150(1):142-151
pubmed: 34528710
Bioorg Med Chem Lett. 2010 Nov 1;20(21):6199-202
pubmed: 20850309
J Chem Inf Model. 2012 Jul 23;52(7):1757-68
pubmed: 22587354
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Eur J Pharmacol. 2008 Apr 14;584(1):40-8
pubmed: 18299127
Curr Drug Targets. 2016;17(14):1580-1585
pubmed: 26521773
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
Nature. 2009 Apr 30;458(7242):1191-5
pubmed: 19252480
CNS Neurol Disord Drug Targets. 2014;13(9):1542-58
pubmed: 25106635
Curr Pharm Des. 2016;22(23):3576-84
pubmed: 27075580
Int J Mol Sci. 2016 Sep 09;17(9):
pubmed: 27618029
Front Immunol. 2014 Mar 03;5:79
pubmed: 24624130
Nat Rev Cancer. 2009 Jan;9(1):57-63
pubmed: 19052556
Drug Discov Today. 2008 Jan;13(1-2):86-93
pubmed: 18190869
Brain Behav Immun. 2010 Jan;24(1):83-95
pubmed: 19679181
Nat Rev Immunol. 2022 Apr;22(4):224-235
pubmed: 34272507
Molecules. 2020 Jan 31;25(3):
pubmed: 32023919
Chemistry. 2010 Aug 9;16(30):9117-22
pubmed: 20583054
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
JAMA. 2013 Mar 20;309(11):1154-62
pubmed: 23512062
Org Lett. 2011 Feb 4;13(3):402-5
pubmed: 21175140
J Med Chem. 2011 Jul 14;54(13):4659-69
pubmed: 21591694
J Immunol Res. 2015;2015:368736
pubmed: 26101781
Pharmaceuticals (Basel). 2022 May 23;15(5):
pubmed: 35631472
Drug Discov Today. 2015 Aug;20(8):1027-34
pubmed: 25975957
J Chem Inf Comput Sci. 2004 May-Jun;44(3):793-806
pubmed: 15154744
Chem Soc Rev. 2015 Nov 21;44(22):8238-59
pubmed: 26248294
J Med Chem. 2013 Jun 13;56(11):4206-23
pubmed: 23656327
Eur J Pharmacol. 2020 May 5;874:172975
pubmed: 32017939
J Allergy Clin Immunol. 2006 May;117(5):1155-62
pubmed: 16675346
Curr Top Med Chem. 2014;14(16):1923-38
pubmed: 25262799
Lancet. 1963 Mar 9;1(7280):552-3
pubmed: 14002455
J Endotoxin Res. 2006;12(5):313-9
pubmed: 17059695
Eur J Med Chem. 2014 Nov 24;87:125-30
pubmed: 25240870
J Med Chem. 2013 Sep 12;56(17):6560-72
pubmed: 23688234
Curr Opin Chem Biol. 2022 Oct;70:102172
pubmed: 35785601
Nat Rev Drug Discov. 2012 Nov;11(11):873-86
pubmed: 23060265
Neuroscience. 2010 Jan 20;165(2):569-83
pubmed: 19833175
Mol Cancer Ther. 2008 Nov;7(11):3642-53
pubmed: 19001446
PLoS One. 2012;7(2):e30839
pubmed: 22363498
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3041-6
pubmed: 18287029
J Chem Inf Model. 2012 Oct 22;52(10):2587-98
pubmed: 22970894
Nature. 2010 Sep 30;467(7315):596-9
pubmed: 20823850
J Comput Aided Mol Des. 2010 Jun;24(6-7):591-604
pubmed: 20354892
N Engl J Med. 1999 Nov 18;341(21):1565-71
pubmed: 10564685
Chemistry. 2017 Feb 3;23(8):1728-1742
pubmed: 27385422
Nat Rev Drug Discov. 2010 Apr;9(4):273-6
pubmed: 20357802
Oncoimmunology. 2018 Oct 11;7(12):e1526250
pubmed: 30524908
Curr Top Med Chem. 2019;19(19):1751-1767
pubmed: 31418662
Trends Pharmacol Sci. 2013 May;34(5):267-72
pubmed: 23582281
Biochem Biophys Res Commun. 2013 May 10;434(3):600-5
pubmed: 23583403
J Comput Chem. 2005 Dec;26(16):1752-80
pubmed: 16211539
J Comput Aided Mol Des. 2007 Dec;21(12):681-91
pubmed: 17899391
Nat Biotechnol. 2012 Jul 10;30(7):571-2
pubmed: 22781662
Drug Discov Today Ther Strateg. 2011 Winter;8(3-4):77-83
pubmed: 22768020
J Neurosci. 2012 Aug 15;32(33):11187-200
pubmed: 22895704
J Med Chem. 2006 Nov 16;49(23):6789-801
pubmed: 17154509
Pharmacology. 2005 Feb;73(2):89-96
pubmed: 15475658
Sci Rep. 2015 Jan 07;5:7657
pubmed: 25563849
Science. 2007 Jun 15;316(5831):1632-4
pubmed: 17569869
J Med Chem. 2014 Feb 27;57(4):1252-75
pubmed: 24471857
Br J Pharmacol. 2022 Jun 27;:
pubmed: 35760458
Nat Struct Mol Biol. 2017 Sep;24(9):743-751
pubmed: 28759049

Auteurs

Lucía Pérez-Regidor (L)

Department of Structural and Chemical Biology, Centro de Investigaciones Biológicas "Margarita Salas", CSIC, C/Ramiro de Maeztu, 9, 28040 Madrid, Spain.

Joan Guzmán-Caldentey (J)

Department of Structural and Chemical Biology, Centro de Investigaciones Biológicas "Margarita Salas", CSIC, C/Ramiro de Maeztu, 9, 28040 Madrid, Spain.

Nils Oberhauser (N)

Department of Structural and Chemical Biology, Centro de Investigaciones Biológicas "Margarita Salas", CSIC, C/Ramiro de Maeztu, 9, 28040 Madrid, Spain.
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.

Carmen Punzón (C)

Centro de Biología Molecular "Severo Ochoa", CSIC-Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Balázs Balogh (B)

Department of Organic Chemistry, Semmelweis University, H ő gyes E. u. 7, H-1092 Budapest, Hungary.

José R Pedro (JR)

Department of Organic Chemistry, Universidad de Valencia, 46100 Valencia, Spain.

Eva Falomir (E)

Department of Inorganic and Organic Chemistry, Escuela Superior de Tecnología y Ciencias Experimentales, University Jaume I, Av. Sos Baynat, s/n, 12006 Castellón, Spain.

Alessandra Nurisso (A)

School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.

Péter Mátyus (P)

Department of Organic Chemistry, Semmelweis University, H ő gyes E. u. 7, H-1092 Budapest, Hungary.

J Carlos Menéndez (JC)

Unidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain.

Belén de Andrés (B)

Immunobiology Department, Carlos III Health Institute, 28220 Madrid, Spain.

Manuel Fresno (M)

Centro de Biología Molecular "Severo Ochoa", CSIC-Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Sonsoles Martín-Santamaría (S)

Department of Structural and Chemical Biology, Centro de Investigaciones Biológicas "Margarita Salas", CSIC, C/Ramiro de Maeztu, 9, 28040 Madrid, Spain.

Classifications MeSH